Takehiko Yokobori

24PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 19, 2026
Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis.

|Jul 17, 2026
High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression.

|Feb 27, 2026
Smaller Oxygen Nanobubbles More Effectively Suppress Colitis and Colon Carcinogenesis than Larger Oxygen Nanobubbles.

Gendensuren Dorjkhorloo, Haruka Okami, Nobutoshi Mutsuki

|Jan 10, 2026
Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil.

Makoto Sakai, Nobuhiro Nakazawa, Kengo Kuriyama

|Sep 30, 2025
Novel therapeutic strategy targeting STMN1 using chlorambucil-conjugated pyrrole-imidazole polyamide in small cell lung cancer.

Ryohei Yoshikawa, Takayoshi Watanabe, Yoichi Ohtaki

|Jul 23, 2025
ASO Visual Abstract: Intratumoral Lipopolysaccharide Positivity Related to Tumor-Associated Macrophage Infiltration and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Shintaro Uchida, Takehiko Yokobori, Kota Yanagisawa

Pageof 4

Frequent Collaborators

5 joint publications

Nobuhiro Nakazawa

4 joint publications

Makoto Sakai

3 joint publications

Navchaa Gombodorj

2 joint publications

Takuya Shiraishi